Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by adamchesson May 06, 2016 12:41pm
177 Views
Post# 24848461

RE:Amber Kanwar's 'deep' dive into CXR pricing

RE:Amber Kanwar's 'deep' dive into CXR pricingSo, it is true that "Concordia" DID NOT INCREASE the price of the pink-eye drug at all during its ownership of AMCo since October 2015. The British Financial Times knows this full well or ought to have known this. Obviously, a bunch of fraudsters trying to add to the short and distort regime that rips off retail investors. Where is the IIROC and OSC protecting our interests? Do your job or why exist? Amber's report still does not help the damage already done by FT and chicken farmer that was aired by BNN. 
<< Previous
Bullboard Posts
Next >>